The HARMONY Alliance [HARMONY & HARMONY PLUS] is a public−private partnership that aims to gather lots of information (big data) on blood cancers, to help answer important research questions which could improve treatments for patients.
A core part of the HARMONY Alliance is its Patient Cluster, which is made up of 9 European patient organizations. Each of these organizations represent the blood cancers the HARMONY Alliance is researching.
The HARMONY Patient Cluster plays an important role in designing research projects to make sure they reflect the patient view. Each patient organization also ensures patients within their communities receive the most up-to-date information on HARMONY projects.
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
